Clinical Research Directory
Browse clinical research sites, groups, and studies.
Oral Versus Intravenous Iron for Anemia Diagnosed After 34 Weeks of Gestation
Sponsor: University of Roma La Sapienza
Summary
This study aims to address this evidence gap by comparing a step-up oral-first strategy with an early IV iron strategy in pregnant women diagnosed with anemia after 34 weeks of gestation.
Official title: Oral Versus Intravenous Iron for Anemia Diagnosed After 34 Weeks of Gestation: A Randomized Controlled Trial
Key Details
Gender
FEMALE
Age Range
18 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
128
Start Date
2026-07-01
Completion Date
2028-09-01
Last Updated
2026-03-20
Healthy Volunteers
No
Conditions
Interventions
Oral iron supplementation
Participants randomized to this group will begin oral iron therapy immediately after diagnosis. The formulation and dosage will follow institutional practice and guideline recommendations
IV iron administration
Participants randomized to this group will receive IV iron within 7 days of diagnosis. The dose will be calculated based on body weight and estimated iron deficit. Oral iron supplementation is not mandated following IV administration.